Wilson Sonsini is pleased to have represented Arcellx in its recently completed acquisition by Gilead Sciences.

Our role as lead legal advisor to Arcellx highlights Wilson Sonsini’s unique strengths as a premier legal partner for life sciences companies, backed by a proven track record in public company M&A. This long-standing relationship with Arcellx, including guiding the company from formation through its successful IPO and collaboration agreement with Kite Pharma, reflects the firm’s commitment to supporting innovative companies in the life sciences industry throughout their entire life cycle.

For more information on the Wilson Sonsini team that represented Arcellx, please see our client highlight announcing the acquisition. For more information, please see Gilead Sciences' news release.